Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-β

Journal of Nutrition

Volumn 139, Issue 3, 2009, Pages 474-481

  Raju, Jayadev ^a   Bielecki, Agnieszka ^a   Caldwell, Donald ^a   Lok, Eric ^a   Taylor, Marnie ^a   Kapal, Kamla ^a   Curran, Ivan ^a   Cooke, Gerard M ^a   Bird, Ranjana P ^b   Mehta, Rekha ^a  

^a TOXICOLOGY RESEARCH DIVISION   (Canada)

^b UNIVERSITY OF WINDSOR   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; ESTROGEN RECEPTOR BETA; ISOFLAVONE DERIVATIVE; CARCINOGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DIET SUPPLEMENTATION; FEMALE; LACTATION; LIFESPAN; MALE; NEWBORN; NONHUMAN; PARENTERAL NUTRITION; PERINATAL PERIOD; PREGNANCY; PRENATAL EXPOSURE; PRENATAL PERIOD; PROTEIN EXPRESSION; RAT; SOYBEAN; SPRAGUE DAWLEY RAT; TUMOR VOLUME; WEANING; ADENOCARCINOMA; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COLON TUMOR; DIET; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; RANDOMIZATION; TUMOR CELL LINE;

RATTUS;

ADENOCARCINOMA; ANIMALS; ANIMALS, NEWBORN; AZOXYMETHANE; CARCINOGENS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DIET; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOFLAVONES; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SOYBEANS;

EID: 62749170009     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.099200     Document Type: Conference Paper

References (46)

1. Badger TM, Ronis MJ, Simmen RC, Simmen FA. Soy protein isolate and protection against cancer. J Am Coll Nutr. 2005;24:S146-9.
2. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006;55:1-12.
3. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98:9-14.
4. Messina M, McCaskill-Stevens W, Lampe JW. Addressing the soy and breast cancer relationship: review, commentary, and workshop pro ceedings. J Natl Cancer Inst. 2006;98:1275-84.
5. Burton JL, Wells M. The effect of phytoestrogens on the female genital tract. J Clin Pathol. 2002;55:401-7.
6. Goetzl MA, Van Veldhuizen PJ, Thrasher JB. Effects of soy phytoes trogens on the prostate. Prostate Cancer Prostatic Dis. 2007;10:216-23.
7. Spector D, Anthony M, Alexander D, Arab L. Soy consumption and colorectal cancer. Nutr Cancer. 2003;47:1-12.
8. Oba S, Nagata C, Shimizu N, Shimizu H, Kametani M, Takeyama N, Ohnuma T, Matsushita S. Soy product consumption and the risk of colon cancer: a prospective study in Takayama, Japan. Nutr Cancer. 2007;57:151-7.
9. Mehta R, Lok E, Caldwell D, Mueller R, Kapal K, Taylor M, Cooke GM, Curran IH. Mammary gland tumor promotion in F1 generation offspring from male and female rats exposed to soy isoflavones for a lifetime. J AOAC Int. 2006;89:1197-206.
10. Murillo G, Choi JK, Pan O, Constantinou AI, Mehta RG. Efficacy of garbanzo and soybean flour in suppression of aberrant crypt foci in the colons of CF-1 mice. Anticancer Res. 2004;24:3049-55.
11. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr. 1998;68:S1394-9.
12. Ohuchi Y, Myojin Y, Shimamoto F, Kashimoto N, Kamiya K, Watanabe H. Decrease in size of azoxymethane induced colon carcinoma in F344 rats by 180-day fermented miso. Oncol Rep. 2005;14:1559-64.
13. Rao CV, Wang CX, Simi B, Lubet R, Kelloff G, Steele V, Reddy BS. Enhancement of experimental colon cancer by genistein. Cancer Res. 1997;57:3717-22.
14. Davies MJ, Bowey EA, Adlercreutz H, Rowland IR, Rumsby PC. Effects of soy or rye supplementation of high-fat diets on colon tumour de velopment in azoxymethane-treated rats. Carcinogenesis. 1999;20: 927-31.
15. Sorensen IK, Kristiansen E, Mortensen A, Nicolaisen GM, Wijnands JA, van Kranen HJ, van Kreijl CF. The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett. 1998;130:217-25.
16. Daly KT, Tracy AC, Malik M, Wang T, Francke-Carroll S, Magnuson BA. Enhanced estrogenic responses and sensitivity to azoxymethane following dietary soy isoflavone supplementation in older female rats. Food Chem Toxicol. 2007;45:628-37.
17. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139: 4252-63.
18. Xiao CW, Wood C, Gilani GS. Nuclear receptors: potential biomarkers for assessing physiological functions of soy proteins and phytoestrogens. J AOAC Int. 2006;89:1207-14.
19. Branham WS, Dial SL, Moland CL, Hass BS, Blair RM, Fang H, Shi L, Tong W, Perkins RG, et al. Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor. J Nutr. 2002;132:658-64.
20. Wada-Hiraike O, Warner M, Gustafsson JA. New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans. 2006;34: 1114-6.
21. Di Leo A, Messa C, Cavallini A, Linsalata M. Estrogens and colorectal cancer. Curr Drug Targets Immune Endocr Metabol Disord. 2001;1:1-12.
22. Jassam N, Bell SM, Speirs V, Quirke P. Loss of expression of oestrogen receptor beta in colon cancer and its association with Dukes' staging. Oncol Rep. 2005;14:17-21.
23. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW Selective loss of estrogen receptor beta in malignant human colon. Cancer Res. 2000; 60:245-8.
24. Nussler NC, Reinbacher K, Shanny N, Schirmeier A, Glanemann M, Neuhaus P, Nussler AK, Kirschner M. Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer. Gend Med. 2008;5:209-17.
25. Akhter M, Inoue M, Kurahashi N, Iwasaki M, Sasazuki S, Tsugane S, for the Japan Public Health Center-Based Prospective Study Group. Dietary soy and isoflavone intake and risk of colorectal cancer in the Japan Public Health Center-Based Prospective Study. Cancer Epidemiol Biomarkers Prev. 2008;17:2128-35.
26. AIN. Report of the ad hoc committee on standards for nutrition studies. J Nutr. 1993;123:1939-51.
27. Bird RP, Yao K, Lasko CM, Good CK. Inability of lowor high-fat diet to modulate late stages of colon carcinogenesis in Sprague-Dawley rats. Cancer Res. 1996;56:2896-9.
28. Whitely LO, Anver MR, Botts S, Jokinen MP. Proliferative lesions of the intestine, salivary glands, oral cavity, and esophagus in rats, GI-1/2/4. In: Guides for toxicologic pathology. Washington, DC: STP/ARP/AFIP; 1996. p. 1-18.
29. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37:147-51.
30. Raju J, Bird RP. Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic trans forming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. Cancer Res. 2003;63:6595-601.
31. Plumb JA, Milroy R, Kaye SB. Effects of the pH dependence of 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan ab sorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 1989;49:4435-40.
32. Raju J, Bird RP. Diosgenin, a naturally occurring steroid [corrected] saponin suppresses 3-hydroxy-3-methylglutaryl CoA reductase expres sion and induces apoptosis in HCT-116 human colon carcinoma cells. Cancer Lett. 2007;255:194-204.
33. Xiao R, Hennings LJ, Badger TM, Simmen FA. Fetal programming of colon cancer in adult rats: correlations with altered neonatal growth trajectory, circulating IGF-I and IGF binding proteins, and testosterone. J Endocrinol. 2007;195:79-87.
34. Xiao R, Su Y, Simmen RC, Simmen FA. Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase. Am J Physiol Gastrointest Liver Physiol. 2008;294:G868-76.
35. Sung HY, Choi YS. Fructooligosaccharide and soy isoflavone suppress colonic aberrant crypt foci and cyclooxygenase-2 expression in dimethylhydrazine-treated rats. J Med Food. 2008;11:78-85.
36. Gee JM, Noteborn HP, Polley AC, Johnson IT. Increased induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats fed diets containing purified genistein or genistein-rich soya protein. Carcinogenesis. 2000; 21:2255-9.
37. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer. 2004;11:537-51.
38. Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I. Genistein inhibits tumor growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall of the MTT assay for evaluating cell growth and survival. Eur J Cancer. 1993;29A:1573-7.
39. Linsalata M, Russo F, Notarnicola M, Guerra V, Cavallini A, Clemente C, Messa C. Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr Cancer. 2005;52: 84-93.
40. Arai N, Ström A, Rafter JJ, Gustafsson JA. Estrogen receptor beta mRNA in colon cancer cells: growth effects of estrogen and genistein. Biochem Biophys Res Commun. 2000;270:425-31.
41. Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC. DNA demethylation and histone deacetylation inhibition co-operate to reexpress estrogen receptor beta and induce apoptosis in prostate cancer cell-lines. Prostate. 2008;68:210-22.
42. Cheng J, Lee EJ, Madison LD, Lazennec G. Expression of estrogen receptor beta in prostate carcinoma cells inhibits invasion and prolifer ation and triggers apoptosis. FEBS Lett. 2004;566:169-72.
43. Treeck O, Pfeiler G, Mitter D, Lattrich C, Piendl G, Ortmann O. Estrogen receptor {beta}l exerts antitumoral effects on SK-OV-3 ovarian cancer cells. J Endocrinol. 2007;193:421-33.
44. Matsumura K, Tanaka T, Kawashima H, Nakatani T. Involvement of the estrogen receptor beta in genistein-induced expression of p21 (waf1/cip1) in PC-3 prostate cancer cells. Anticancer Res. 2008;28: 709-14.
45. Chatzinikolaou G, Nikitovic D, Stathopoulos EN, Velegrakis GA, Karamanos NK, Tzanakakis GN. Protein tyrosine kinase and estrogen receptor-dependent pathways regulate the synthesis and distribution of glycosaminoglycans/ proteoglycans produced by two human colon cancer cell lines. Anticancer Res. 2007;27:4101-6.
46. Kim EJ, Shin HK, Park JH. Genistein inhibits insulin-like growdh factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growdi inhibitory effect of Genistein. J Med Food. 2005;8:431-8.